Long-Term Consequences ofHelicobacter pyloriEradication
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 29 (sup205) , 38-44
- https://doi.org/10.3109/00365529409091408
Abstract
Long-term infection with Helicobacter pylori could potentially lead to asymptomatic chronic gastritis, chronic dyspepsia, duodenal ulcer disease, gastric ulcer disease, or gastric malignancy, including both adenocarcinoma and B-cell lymphoma. Currently, the two most important indications for eradication of this bacterium are proven H. pylori-associated duodenal or gastric ulcer disease. Many studies have shown that successful eradication of H. pylori dramatically reduces the rate of duodenal ulcer relapse, and long-term follow-up data appear to support the claim ‘no H. pylori, no gastritis; no gastritis, no ulcer’, which follows on from the old. but certainly valid, dictum ‘no acid, no ulcer’. Furthermore, absence of relapse parallels the marked improvement in gastric histology (e.g. regression of gastritis). Whether there is concomitant regression of gastric metaplasia in the duodenal bulb is, however, controversial. Despite the rather limited data for H. pylori-associated gastric ulcer, successful eradication of the organism has been equated with cure of peptic ulcer disease. Again, eradication parallels a substantial improvement in gastric histology. Although eradication of H. pylori is not currently recommended in asymptomatic individuals or dyspeptics, it has been well documented in previous studies that successful eradication improves the gastric histology in patients with H. pylori-associated dyspepsia. From these studies, it appears that the disappearance of polymorphs from the inflammatory infiltrate occurs rather rapidly after eradication, although regression of the mononuclear component of the inflammatory reaction is more prolonged.Keywords
This publication has 43 references indexed in Scilit:
- Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patientsEuropean Journal of Gastroenterology & Hepatology, 1993
- Decreased relapse rate after antibacterial treatment of Helicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trialEuropean Journal of Gastroenterology & Hepatology, 1993
- Duodenal Ulcer and Eradication ofHelicobacter pyloriin a Developing Country An 18-Month Follow-up StudyScandinavian Journal of Gastroenterology, 1992
- Longitudinal Study of Influence ofHelicobacter pylorion Current Risk of Duodenal Ulcer RelapseScandinavian Journal of Gastroenterology, 1992
- Duodenal ulcer relapse after eradication of Helicobacter pyloriThe Lancet, 1991
- Suicidal destruction of Helicobacter pylori: metabolic consequence of intracellular accumulation of ammonia.Journal of Clinical Pathology, 1991
- Helicobacter pyloriand Chronic Active Inflammation of the Duodenum and Stomach in Duodenal Ulcer Patients Treated with Ranitidine, Misoprostol, or an Acid-Neutralizing AgentScandinavian Journal of Gastroenterology, 1991
- Chronic effect of intragastric ammonia on gastric mucosal structures in ratsDigestive Diseases and Sciences, 1991
- Reduction of gastric ulcer recurrence after suppression of Helicobacter pylori by cefixime.Gut, 1990
- Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa.Gut, 1988